Drug firms fighting ‘tooth and nail’ against California ballot measure
Drugmakers including Eli Lilly and Co. are becoming increasingly vocal in fighting a California ballot proposition designed to bring down prices on prescription medicine.
Health Care Businesses
Articles
Lilly cancer drug lands accelerated FDA approval
Lartruvo is the first front-line therapy approved by the FDA to treat soft tissue sarcomas since doxorubicin more than 40 years ago.
Indy-based NICO works for acceptance of less invasive brain surgery tools
Currently, only about 2-4 percent of U.S. brain surgeries for tumors, strokes and other abnormalities are done with NICO’s low-invasive approach.
Lilly pledges $90 million to improve global drug access
Eli Lilly and Co. is pledging $90 million over five years to improve access to treatment for diabetes, cancer and tuberculosis in developing countries—the latest push in its philanthropic strategy of building health care systems around the world and increasing the market for its prescription drugs.
Indy EMS analyzes data to spot, share trends in public health
IEMS has been at the forefront of big data, unifying granular information into a real-time public health picture and spurring action across other government agencies.
Wall Street analysts jumping on Lilly train
For more than two years, Eli Lilly and Co. has pushed the message that the worst days are over and a brighter future is just around the corner. Now, finally, Wall Street is starting to believe.
Americans getting fed up over high drug prices
A new poll shows that a growing number of people feel drug prices are unreasonable, and they favor a variety of government actions to keep prices down.
Analysis: Diabetes drug price war likely to claim more casualties
Pharma giant Novo Nordisk announced Thursday that it is cutting 1,000 jobs after slashing forecasts for 2016, citing lower prices for diabetes drugs. Novo and competitors such as Indianapolis-based Eli Lilly will likely have to keep tightening their belts as prices and profit margins fall, experts say.
Health advocates gain favor to help employees navigate health care complexities
Employers began hiring health advocates in earnest nationwide about four years ago, fueled by implementation of the Affordable Care Act and growing public awareness that provider rates and quality can differ greatly.
The Interview Issue: Billie Dragoo
Founder of RepuCare, a 200-employee medical staffing company, Billie Dragoo has become one of central Indiana’s most fervent advocates for women. She’s a past CEO and board chairwoman of the National Association of Women Business Owners and co-founder of the Indiana Conference for Women.
The Interview Issue: Betty Cockrum
Betty Cockrum’s job is not one for the faint of heart. As president and CEO of Planned Parenthood of Indiana and Kentucky, she is often in the spotlight, fighting to maintain reproductive and abortion services across the state. But despite the high-profile role, Cockrum says she’s actually an introvert.
Super-sized laundry co-op serves 55 hospitals, 700 clinics
Just two years after United Hospital Services pushed into Kokomo by merging with North Central Indiana Linen Service, the co-op is planning its next move—this time into northwest Indiana.
Humble medical office buildings selling for kingly sums
The latest local example of the sizzling market is the three-story Community Health Pavilion, which sold last week for $286 a square foot—far more than the per-square-foot price in two recent office complex transactions.
Under fire, maker of EpiPen launching cheaper, generic version
Mylan will start selling a cheaper version of the emergency allergy treatment after absorbing waves of criticism over a growing list price that made it unaffordable for many patients.
The most unsexy sex report you’ll read today
A 214-page court ruling on a patent dispute involving testosterone treatments is a window into the very clinical world of sex drugs.
Lilly, partner lose court fight over testosterone treatment
Eli Lilly and Co. and its partner cannot stop competitors from selling generic versions of testosterone treatment Axiron, a federal judge in Indianapolis has ruled.
St. Vincent plans to build ‘micro-hospitals’ throughout area
St. Vincent will expand its footprint in central Indiana by opening eight small hospitals where patients can get treated for medical conditions that aren’t life-threatening. The first four locations were announced Monday.
Lilly drug for Alzheimer’s gets fast-tracked by FDA
Named AZD3293, the drug belongs to a novel class of drugs that block production of amyloid, a protein that causes plaque to build up in the brain of Alzheimer’s patients.
Carmel doctor found not guilty of charges from 2014 raid
Judge Steve Nation found that Dr. Larry Ley had met all of the standards for prescribing medicine for drug addiction after a bench trial in Hamilton County Superior Court.
Cialis users sue Lilly, claiming drug has ties to skin cancer
Seven men who took Cialis pills to treat erectile dysfunction sued Indianapolis drugmaker Eli Lilly and Co. this week, claiming they later suffered from skin cancer that was related to the medicine.